OpenAI’s New AI Model Rosalind Could Shave Years Off Drug Discovery. You Prob…

In recent developments, gPT-Rosalind is OpenAI’s first domain-specific model, built for drug discovery and life sciences—and it’s not for everyone. Looking closer, market participants highlight key drivers such as liquidity…